Filing Details
- Accession Number:
- 0001213900-19-020706
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-21 16:07:46
- Reporting Period:
- 2019-10-18
- Accepted Time:
- 2019-10-21 16:07:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658544 | Edward Paul Kelly | C/O Relmada Therapeutics, Inc. 880 Third Avenue, 12Th Floor New York, NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-18 | 1,000 | $18.99 | 123,121 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-18 | 100 | $19.04 | 123,221 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-18 | 400 | $19.07 | 123,621 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-18 | 100 | $19.08 | 123,721 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-18 | 200 | $19.10 | 123,921 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-18 | 100 | $19.15 | 124,021 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-10-18 | 3,100 | $19.20 | 127,121 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
